Skip to main content
    Back to episode
    Episode 55 · January 14, 2026 · 53m listen · 1,162 words · ~6 min read

    Why MedTech is the Future of Entrepreneurship with Omar Khateeb | Ep. 54 - Full Transcript | The Med Device Cyber Podcast

    Read the complete, searchable transcript of Episode 55 of The Med Device Cyber Podcast - expert conversations on medical device cybersecurity, FDA premarket and postmarket guidance, SBOM management, threat modeling, and penetration testing.

    Prefer the listening experience? Open the episode page for the synopsis, key takeaways, topics, and Apple / YouTube listen links.

    Episode summary

    This episode of The Med Device Cyber Podcast features Omar Khateeb, host of The State of MedTech podcast. Khateeb discusses the current landscape of the MedTech industry, highlighting a shift from a period of consolidation with a few large strategics to the emergence of "mini-strategics" and increased M&A activity. This new environment offers more access to capital for startups, moving beyond traditional venture capital to include private investors and corporate investment arms. The conversation delves into the growing importance of cybersecurity in MedTech, particularly with the rise of AI-enabled and digitally integrated medical devices. Khateeb and the hosts emphasize that companies must de-risk cybersecurity from day one to attract strategic buyers and avoid regulatory issues like FDA warning letters. The discussion also touches on the proactive approach of the FDA in issuing guidance for AI in medical devices, and the concerns of healthcare delivery organizations and insurance companies regarding device security. The episode further explores the innovative business models needed in MedTech, advocating for a focus on market fit, reimbursement strategies, and regulatory compliance at the outset of product development. The hosts also touch on why entrepreneurship in medtech may be less

    Key takeaways from this episode

    • The MedTech industry is transitioning from consolidation by large strategics to a landscape with emerging “mini-strategics” and increased M&A activity.
    • This shift provides greater access to capital for MedTech startups, moving beyond traditional venture capital to include private and corporate investments.
    • Cybersecurity must be a foundational consideration from the initial stages of MedTech product development to attract strategic buyers and avoid regulatory complications like FDA warning letters.
    • The FDA is proactively addressing the cybersecurity implications of AI-enabled medical devices, demonstrating an increased regulatory focus on this area.
    • Innovative business models in MedTech need to prioritize market fit, effective reimbursement strategies, and adherence to regulatory classifications from inception.
    • Despite perceived challenges in attracting talent and capital, the impact potential in MedTech is significant, requiring better industry marketing and a willingness for 'moonshot' innovation.

    Full episode transcript

    Page 1 of 2· Paragraphs 1 - 12
    Do you think the state of MedTech in cybersecurity is improving at all, or are we getting worse? I think it's improving. What do you think, Trevor, about the industry and cybersecurity? I would hope that it's a little bit more well-structured than some of these other situations which we've seen come up in similar cases in the past. There's got to be—and again, these are part of larger macroeconomic issues, I don't have an answer—but I'll give you an example on the capital side. Welcome back to another episode of The Med Device Cyber Podcast. Today we have a guest, Omar. He's going to talk to us about the state of MedTech, and he's been doing quite a few podcasts. I don't know what episode number you're on, but you've interviewed and talked to a lot of people in the industry, haven't you, Omar? Yes, definitely, definitely. I mean, you guys have been on the show before when we did a webinar together, and we have your episode coming out soon. But yeah, I think we're 330. It's in the 300s right now. All right, so you've got a pretty good pulse after 300-something discussions with people in MedTech. So it'll be interesting to see how you feel the industry has shifted over the years, and we'll talk a little bit about cybersecurity as well, because I know we talked about that in the past. I'm Christian Espinosa, the co-host, and I'm here joining with Trevor, our co-host. And I think you two are coming to us from NorCal and SoCal, is that right? That's right. I'm in SoCal. I didn't know Trevor was in NorCal now. I thought Charles was like the international man of mystery. He's always like somewhere in the world. Yeah, I'm settling down for a few more hours here, actually, even in San Francisco, and then back on the road again. I do have an apartment here that is now becoming an expensive storage unit, but yeah, very small. That is probably the world's most expensive storage unit for sure. I would change that quickly, or just move to the East Bay. I don't know. Yeah, I think it's hard to beat the San Francisco just closeness of everything, but yeah, I figure I've got to spend a little bit more time here to actually enjoy the closeness of everything. Awesome. Why don't we start off, Omar, with you introducing yourself and giving a little bit of background about what you do and what your organization does? And we can go from there. Yeah, wonderful, and again, thanks for having me on the show. It's an honor to be on. You have a fantastic show and, more importantly, I love podcasts that have a very specific niche. You guys have a very nice focus on technology and cybersecurity. So what do I do? I've been in the industry a little over 15 years, started off in medical school before I transitioned into surgical robotics as a sales guy, moved into marketing, and, as they say, the rest is history. A few years ago, I decided to start my own business. It started off with me selling online courses because I just didn't want to deal with anybody. I literally wanted to make WiFi money and just sell a product and not deal with anybody. But then over time, I was like, yeah, you know, I'm actually really good at marketing and market engineering. And so I started my own firm. So our company, Marketcraft, our whole focus is on essentially the whole idea behind market engineering. A lot of people know about what it takes or what it looks like to create a category, but in order for that to actually work, you have to be able to engineer a market, or in our case, craft a market. So you can drive adoption, raise awareness with investors, and even leverage strategics for a buyout. And so we work with a lot of early-stage companies, anywhere from pre-FDA, pre-commercial, all the way through commercial. We don't necessarily work with strategics, but in our product roadmap, I think for every small business, especially if you're service-oriented, at some point, you're going to end up working with large strategics in the future. What people know me for, they don't really know me for Marketcraft, what they know me for, which is going to change; we just went through a name change. Now we're Marketcraft, away from Kativ and Co, so there will be a lot of really great thought leadership content produced on that end so that people know what we do and, more importantly, how they can spend money with us. But what everybody knows me for is really 'State of MedTech,' the podcast. With that show, I interview investors, CEOs, and industry experts like yourselves, and really just to have a pulse on the industry. And so as a result of that, I guess I'm one of the few people in the space who really has a true pulse on things because I'm talking to so many different people, from investors and CEOs down to even salespeople. Awesome. So what is the pulse on MedTech? Are we getting better, getting worse? What is the pulse? What would you say?
    1 / 2